Nov 2023 $5 M No. 6 $2 to $10 million 9
Minerva Biotechnologies Corp.: Raise no. 6, Nov 2023 × Investors in this round 9 investors had bought by the notice of Dec 5, 2023: 9 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $5 M of $8 M offered; $3 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last more than a year
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Cynthia Bamdad · Executive Officer, Director James R. Bridges · Director Joseph Anthony Nathan · Director Kenneth Anthony Reed · Director Kenneth Kosik · Director Lawrence Anthony Coolidge · Director Robert Staszewski · Director Ronald R. Axelrod · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Cynthia Bamdad, President & Chief Executive Officer. Source: SEC Form D, newest notice filed Dec 5, 2023. Read the notice at the SEC .
equity SEC Oct 2019 $24 M No. 5 $10 to $50 million 65
Minerva Biotechnologies Corp.: Raise no. 5, Oct 2019 × Investors in this round 65 investors had bought by the notice of Jan 28, 2022: 65 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $24 M of $30 M offered; $6 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last more than a year
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Cynthia Bamdad · Executive Officer, Director · President & Chief Executive Officer James R. Bridges · Director Joseph Anthony Nathan · Director Kenneth Anthony Reed · Director Kenneth Kosik · Director Lawrence Anthony Coolidge · Director Robert Staszewski · Director Ronald R. Axelrod · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the amounts: “Offering is Closed.”Signed by Cynthia Bamdad, President & Chief Executive Officer. Source: SEC Form D and 1 amendment, newest notice filed Jan 28, 2022. Read the notice at the SEC .
equity SEC Mar 2019 $4 M No. 4 $2 to $10 million 9
Minerva Biotechnologies Corp.: Raise no. 4, Mar 2019 × Investors in this round 9 investors had bought by the notice of Apr 5, 2019: 9 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $4 M of $12 M offered; $8 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last more than a year
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Nevada People named in the notice Cynthia Bamdad · Executive Officer, Director · President & Chief Executive Officer James F. Bridges · Director Joseph Anthony Nathan · Director Kenneth Anthony Reed · Director Kenneth Kosik · Director Lawrence Anthony Coolidge · Director Normand F. Smith · Director Robert Staszewski · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Cynthia Bamdad, President & Chief Executive Officer. Source: SEC Form D, newest notice filed Apr 5, 2019. Read the notice at the SEC .
equity SEC Oct 2014 $29 M No. 3 $10 to $50 million 79
Minerva Biotechnologies Corp.: Raise no. 3, Oct 2014 × Investors in this round 79 investors had bought by the notice of Oct 2, 2018: 79 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $29 M of $31 M offered; $2 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last more than a year
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Nevada People named in the notice Cynthia Bamdad · Executive Officer, Director · President & Chief Executive Officer James F. Bridges · Director Joseph Anthony Nathan · Director Kenneth Anthony Reed · Director Kenneth Kosik · Director Lawrence Anthony Coolidge · Director Normand F. Smith · Director Robert Staszewski · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Cynthia Bamdad, President & Chief Executive Officer. Source: SEC Form D and 1 amendment, newest notice filed Oct 2, 2018. Read the notice at the SEC .
equity SEC Nov 2010 $5 M No. 2 $2 to $10 million 17
Minerva Biotechnologies Corp.: Raise no. 2, Nov 2010 × Investors in this round 17 investors had bought by the notice of Nov 17, 2010: 17 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $5 M of $6 M offered; $1 M still to sell
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Nevada People named in the notice Cynthia Bamdad · Executive Officer, Director Kenneth Kosik · Director Kenneth Reed · Director Normand Smith · Director Robert Staszewski · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the amounts: “Not including warrants which could amount for additional $1,130,000.”Signed by Cynthia Bamdad, President. Source: SEC Form D, newest notice filed Nov 17, 2010. Read the notice at the SEC .
equity, options SEC Jul 2009 $2 M No. 1 Under $2 million 20
Minerva Biotechnologies Corp.: Raise no. 1, Jul 2009 × Investors in this round 20 investors had bought by the notice of Feb 23, 2010: 20 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $2 M of $5 M offered; $3 M still to sell
Smallest investment taken $50,000
What was sold equity
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Nevada People named in the notice Cynthia Bamdad · Executive Officer, Director, Promoter Kenneth Kosik · Director Kenneth Reed · Director Normand Smith · Director Robert Staszewski · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Cynthia Bamdad, President. Source: SEC Form D, newest notice filed Feb 23, 2010. Read the notice at the SEC .
equity SEC